SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-079129
Filing Date
2004-05-05
Accepted
2004-05-05 14:33:44
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 354746
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8846
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8804
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3058
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2947
  Complete submission text file 0001193125-04-079129.txt   380409
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 04781055
SIC: 8731 Services-Commercial Physical & Biological Research